We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.37B
AUM Growth
+$566M
Cap. Flow
+$197M
Cap. Flow %
4.52%
Top 10 Hldgs %
75.62%
Holding
311
New
26
Increased
196
Reduced
22
Closed
17

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$25.9M
2
MSGS icon
Madison Square Garden
MSGS
+$23.3M
3
MSFT icon
Microsoft
MSFT
+$14.8M
4
AMZN icon
Amazon
AMZN
+$12.7M
5
NVDA icon
NVIDIA
NVDA
+$12.5M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$41.6M
2
DINO icon
HF Sinclair
DINO
+$6.4M
3
UNH icon
UnitedHealth
UNH
+$3.72M
4
TPYP icon
Tortoise North American Pipeline ETF
TPYP
+$2.48M
5
FANG icon
Diamondback Energy
FANG
+$2.11M

Sector Composition

Rank Sector Weight
1 Healthcare 56.07%
2 Technology 8.45%
3 Energy 6.73%
4 Consumer Discretionary 4.64%
5 Utilities 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
51
AT&T
T
$165B
$7.19M 0.16%
248,342
+16,970
+7% +$468K
UBER icon
52
Uber
UBER
$134B
$6.96M 0.16%
74,561
+3,410
+5% +$281K
PLD icon
53
Prologis
PLD
$138B
$6.7M 0.15%
63,699
+8,220
+15% +$862K
NDAQ icon
54
Nasdaq
NDAQ
$51.5B
$6.5M 0.15%
72,685
+217
+0.3% +$17.3K
NI icon
55
NiSource
NI
$22.4B
$6.36M 0.15%
157,697
+6,958
+5% +$273K
KMB icon
56
Kimberly-Clark
KMB
$36.4B
$6.22M 0.14%
48,225
+1,055
+2% +$143K
TECX
57
Tectonic Therapeutic
TECX
$573M
$6.02M 0.14%
302,953
– –
BMY icon
58
Bristol-Myers Squibb
BMY
$127B
$5.95M 0.14%
128,508
+7,811
+6% +$383K
PPL
59
PPL Corp
PPL
$27.3B
$5.56M 0.13%
164,172
+11,609
+8% +$404K
IWF icon
60
iShares Russell 1000 Growth ETF
IWF
$122B
$5.24M 0.12%
49,320
+48
+0.1% +$4.59K
GOOGL icon
61
Alphabet (Google) Class A
GOOGL
$3.91T
$5.13M 0.12%
29,087
+21,909
+305% +$3.59M
UNP icon
62
Union Pacific
UNP
$183B
$5.02M 0.11%
21,835
+542
+3% +$120K
HON icon
63
Honeywell
HON
$77.1B
$4.92M 0.11%
22,428
+1,071
+5% +$217K
PEP icon
64
PepsiCo
PEP
$186B
$4.34M 0.1%
32,870
+929
+3% +$125K
NTR icon
65
Nutrien
NTR
$32.7B
$4.01M 0.09%
68,824
+2,501
+4% +$141K
ALL icon
66
Allstate
ALL
$66.9B
$4M 0.09%
19,892
+165
+0.8% +$32.9K
ORCL icon
67
Oracle
ORCL
$331B
$3.94M 0.09%
18,020
+71
+0.4% +$11.5K
COST icon
68
Costco
COST
$415B
$3.91M 0.09%
3,949
+117
+3% +$116K
AJG icon
69
Arthur J. Gallagher & Co
AJG
$63.7B
$3.88M 0.09%
12,116
+564
+5% +$186K
CL icon
70
Colgate-Palmolive
CL
$72.6B
$3.82M 0.09%
42,072
+1,875
+5% +$171K
GPC icon
71
Genuine Parts
GPC
$17.1B
$3.76M 0.09%
30,961
+1,775
+6% +$214K
RTX icon
72
RTX Corp
RTX
$287B
$3.49M 0.08%
23,920
+726
+3% +$96.7K
WMB icon
73
Williams Companies
WMB
$90.5B
$3.35M 0.08%
53,398
+2,904
+6% +$171K
XOM icon
74
ExxonMobil
XOM
$651B
$3.29M 0.08%
30,522
+793
+3% +$84.8K
ACN icon
75
Accenture
ACN
$89.9B
$3.06M 0.07%
10,241
+48
+0.5% +$14.6K
1 2
3
4 5

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Bollard Group's Q2 2025 Portfolio in Review

As of Q2 2025, Bollard Group held 311 positions worth $4.37B, up 15% from $3.81B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bollard Group deployed $197M of net new capital in Q2 2025, opening 26 new positions and adding to 196 existing holdings. Its largest new stake was Madison Square Garden: 121,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 61% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Boston Scientific, an estimated $41.6M trimmed.

  • Bollard Group's largest Q2 2025 buy was Madison Square Garden: 121,000 shares worth $25.3M.
  • Bollard Group added most to Thermo Fisher Scientific in Q2 2025, an estimated $25.9M increase.
  • Bollard Group's biggest Q2 2025 reduction was Boston Scientific, cutting an estimated $41.6M.
  • Bollard Group fully exited HF Sinclair in Q2 2025, selling an estimated $6.4M.
  • Bollard Group's ten largest holdings make up 76% of its $4.37B portfolio in Q2 2025.
  • Bollard Group opened 26 new positions and closed 17 in Q2 2025.
  • Bollard Group's portfolio value rose 15% quarter-over-quarter to $4.37B.

Based on Bollard Group's 13F filing for Q2 2025, filed 13 Aug 2025.